Hanna Fares

The trafficking of macromolecules between different compartments is an essential process in all eukaryotic cells and is used to maintain cellular integrity, to interact with the extracellular environment, and to generally modulate various cellular activities. Numerous advances have been made in understanding different pathways of membrane trafficking and in elucidating some of the factors that regulate them; these advances have demonstrated a striking conservation of these pathways among all eukaryotic cells.

We are studying membrane trafficking using primarily the nematode Caenorhabditis elegans as a model system.  We are also using mouse macrophages as a parallel system that complements the genetic studies we carry out in C. elegans.  Current projects in the laboratory are:

1) The analysis of endocytosis.  We have identified several novel regulators that are required for endocytosis by specialized scavenger cells called coelomocytes in C. elegans.

2) The analysis of lysosomal transport, focusing on CUP-5 in C. elegans and its mammalian ortholog mucolipin-1.  Mutations in MCOLN1, the gene that encodes mucolipin-1, results in the lysosome storage disorder Mucolipidosis type IV.

3) The analysis of suppressors of cup-5 mutant defects.  We identified several suppressors of cup-5 mutant defects.  The analysis of these suppressors will identify the molecular events that exacerbate cup-5 mutant phenotypes.  These suppressors also constitute leads towards identifying treatments for Mucolipidosis type IV.

4) The characterization of a novel quality control pathway that is used for the recognition and degradation of misfolded integral membrane proteins at the plasma membrane.

Roles Of Cup 5, The Caenorhabditis Elegans Orthologue Of Human Trpml1, In Lysosome And Gut Granule Biogenesis. Source: Bmc Cell Biology
June 11th, 2010 PMID: 20540742 Hanna Fares
BACKGROUND:<br>CUP-5 is a Transient Receptor Potential protein in C. elegans that is the orthologue of mammalian TRPML1. Loss of TRPML1 results in the lysosomal storage disorder Mucolipidosis type IV. Loss of CUP-5 results in embryonic lethality and the accumulation of enlarged yolk granules in developing intestinal cells. The embryonic lethality of cup-5 mutants is rescued by mutations in mrp-4, which is required for gut granule differentiation. Gut granules are intestine-specific lysosome-related organelles that accumulate birefringent material. This link between CUP-5 and gut granules led us to determine the roles of CUP-5 in lysosome and gut granule biogenesis in developing intestinal cells.<br><br>RESULTS:<br>We show that CUP-5 protein localizes to lysosomes, but not to gut granules, in developing intestinal cells. Loss of CUP-5 results in defects in endo-lysosomal transport in developing intestinal cells of C. elegans embryos. This ultimately leads to the appearance of enlarged terminal vacuoles that show defective lysosomal degradation and that have lysosomal and endosomal markers. In contrast, gut granule biogenesis is normal in the absence of CUP-5. Furthermore, loss of CUP-5 does not result in inappropriate fusion or mixing of content between lysosomes and gut granules.<br><br>CONCLUSIONS:<br>Using an in vivo model of MLIV, we show that there is a defect in lysosomal transport/biogenesis that is earlier than the presumed function of TRPML1 in terminal lysosomes. Our results indicate that CUP-5 is required for the biogenesis of lysosomes but not of gut granules. Thus, cellular phenotypes in Mucolipidosis type IV are likely not due to defects in lysosome-related organelle biogenesis, but due to progressive defects in lysosomal transport that lead to severe lysosomal dysfunction.<br><br>
Detoxification Of Multiple Heavy Metals By A Half Molecule Abc Transporter, Hmt 1, And Coelomocytes Of Caenorhabditis Elegans. Source: Plo S One
March 5th, 2010 PMID: 20221439 Hanna Fares
BACKGROUND:<br>Developing methods for protecting organisms in metal-polluted environments is contingent upon our understanding of cellular detoxification mechanisms. In this regard, half-molecule ATP-binding cassette (ABC) transporters of the HMT-1 subfamily are required for cadmium (Cd) detoxification. HMTs have conserved structural architecture that distinguishes them from other ABC transporters and allows the identification of homologs in genomes of different species including humans. We recently discovered that HMT-1 from the simple, unicellular organism, Schizosaccharomyces pombe, SpHMT1, acts independently of phytochelatin synthase (PCS) and detoxifies Cd, but not other heavy metals. Whether HMTs from multicellular organisms confer tolerance only to Cd or also to other heavy metals is not known.<br><br>METHODOLOGY/PRINCIPAL FINDINGS:<br>Using molecular genetics approaches and functional in vivo assays we showed that HMT-1 from a multicellular organism, Caenorhabditis elegans, functions distinctly from its S. pombe counterpart in that in addition to Cd it confers tolerance to arsenic (As) and copper (Cu) while acting independently of pcs-1. Further investigation of hmt-1 and pcs-1 revealed that these genes are expressed in different cell types, supporting the notion that hmt-1 and pcs-1 operate in distinct detoxification pathways. Interestingly, pcs-1 and hmt-1 are co-expressed in highly endocytic C. elegans cells with unknown function, the coelomocytes. By analyzing heavy metal and oxidative stress sensitivities of the coelomocyte-deficient C. elegans strain we discovered that coelomocytes are essential mainly for detoxification of heavy metals, but not of oxidative stress, a by-product of heavy metal toxicity.<br><br>CONCLUSIONS/SIGNIFICANCE:<br>We established that HMT-1 from the multicellular organism confers tolerance to multiple heavy metals and is expressed in liver-like cells, the coelomocytes, as well as head neurons and intestinal cells, which are cell types that are affected by heavy metal poisoning in humans. We also showed that coelomocytes are involved in detoxification of heavy metals. Therefore, the HMT-1-dependent detoxification pathway and coelomocytes of C. elegans emerge as novel models for studies of heavy metal-promoted diseases.<br><br>
Discrete Domains Of March1 Mediate Its Localization, Functional Interactions, And Posttranscriptional Control Of Expression. Source: Journal Of Immunology (Baltimore, Md. : 1950)
October 30th, 2009 PMID: 19880452 Hanna Fares
Within APCs, ubiquitination regulates the trafficking of immune modulators such as MHC class II and CD86 (B7.2) molecules. MARCH1 (membrane-associated RING-CH), a newly identified ubiquitin E3 ligase expressed in APCs, ubiquitinates MHC class II, thereby reducing its surface expression. Following LPS-induced maturation of dendritic cells, MARCH1 mRNA is down-regulated and MHC class II is redistributed to the cell surface from endosomal compartments. Here, we show that MARCH1 expression is also regulated at the posttranscriptional level. In primary dendritic cell and APC cell lines of murine origin, MARCH1 had a half-life of <30 min. MARCH1 degradation appears to occur partly in lysosomes, since inhibiting lysosomal activity stabilized MARCH1. Similar stabilization was observed when MARCH1-expressing cells were treated with cysteine protease inhibitors. Mutational analyses of MARCH1 defined discrete domains required for destabilization, proper localization, and functional interaction with substrates. Taken together, these data suggest that MARCH1 expression is regulated at a posttranscriptional level by trafficking within the endolysosomal pathway where MARCH1 is proteolyzed. The short half-life of MARCH1 permits very rapid changes in the levels of the protein in response to changes in the mRNA, resulting in efficient induction of Ag presentation once APCs receive maturational signals.<br><br>
Displaying 3 of 3 publications more | all